1. Home
  2. ACNB vs VOR Comparison

ACNB vs VOR Comparison

Compare ACNB & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACNB Corporation

ACNB

ACNB Corporation

HOLD

Current Price

$46.48

Market Cap

522.8M

Sector

Finance

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$13.51

Market Cap

562.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACNB
VOR
Founded
1857
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
522.8M
562.6M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
ACNB
VOR
Price
$46.48
$13.51
Analyst Decision
Buy
Buy
Analyst Count
2
10
Target Price
$49.50
$64.78
AVG Volume (30 Days)
31.4K
549.7K
Earning Date
04-23-2026
01-01-0001
Dividend Yield
3.27%
N/A
EPS Growth
N/A
2.86
EPS
3.60
N/A
Revenue
$191,821,000.00
N/A
Revenue This Year
$13.18
N/A
Revenue Next Year
$1.91
N/A
P/E Ratio
$12.93
N/A
Revenue Growth
45.10
N/A
52 Week Low
$35.70
$0.13
52 Week High
$53.89
$49.95

Technical Indicators

Market Signals
Indicator
ACNB
VOR
Relative Strength Index (RSI) 30.98 43.87
Support Level $42.84 $11.27
Resistance Level $46.53 $14.73
Average True Range (ATR) 1.49 1.16
MACD -0.51 -0.17
Stochastic Oscillator 7.33 10.66

Price Performance

Historical Comparison
ACNB
VOR

About ACNB ACNB Corporation

ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Share on Social Networks: